XML 24 R12.htm IDEA: XBRL DOCUMENT
v3.26.1

Inventory, Net | 6 Months Ended
--- | ---
Jun. 30, 2026
Inventory Disclosure [Abstract] |
Inventory, Net | 4. INVENTORY, NET The components of inventory, net were as follows:
|  | June 30, |  |  | December 31, |
(in thousands) |  | 2026 |  |  | 2025 |
Product inventory – Pellets |  | $ | 7,392 |  |  | $ | 6,694 |
Pellets in process |  |  | 1,008 |  |  |  | 1,524 |
Raw materials |  |  | 757 |  |  |  | 556 |
Less: Obsolete and expired pellet allowance |  |  | (1,793 | ) |  |  | (3,153 | )
Pellet inventory, net |  |  | 7,364 |  |  |  | 5,621 |
Product inventory – Dietary supplements |  |  | 7,581 |  |  |  | 10,085 |
Raw materials |  |  | 3,723 |  |  |  | 3,723 |
Less: Obsolete and expired dietary supplement allowance |  |  | (337 | ) |  |  | (365 | )
Dietary supplement inventory, net |  |  | 10,967 |  |  |  | 13,443 |
Inventory, net |  | $ | 18,331 |  |  | $ | 19,064 |
On January 26, 2026, the Company announced its subsidiary, Asteria Health, issued a voluntary recall of specific lots of hormone pellets shipped by Asteria Health between May 20, 2025 and January 19, 2026 due to the potential presence of metal particulate matter (the “January 2026 Voluntary Recall”). The Company evaluated its pellet inventory on hand as of the date of the recall, and determined the pellet inventory lots impacted by the recall were impaired as of December 31, 2025. As a result, the Company recorded an impairment charge of $1.3 million to write-down the impacted pellet inventory to net realizable value, which is reflected in inventory, net on the unaudited condensed consolidated balance sheet for the year ended December 31, 2025. The Company did no t record any additional recall-related impairment charges to its pellet inventory during the three and six months ended June 30, 2026.

X
- References No definition available. + Details
Name: | us-gaap_InventoryDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 330 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/330/tableOfContent + Details
Name: | us-gaap_InventoryDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration